Search

everythinglearnresearchcommunity

for

Search:↓

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

The "color-transition sign" helps tell apart alopecia areata incognita from telogen effluvium by looking at hair color changes.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

The workshop aimed to improve hair loss disorder diagnosis and understanding.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

Different cells affect hair follicle blood vessels, endothelial cells react differently to inflammation and oxidized fats, and prasugrel better protects heart vessels during a procedure than clopidogrel.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

Platelet-rich plasma therapy may help treat folliculitis decalvans but benefits might not last without ongoing treatment.

Two trichoscopic patterns found in hair loss: diffuse fibrotic and androgenetic alopecia, affecting treatment choice and regrowth chances.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

A man had an allergic reaction to minoxidil, which stopped after he discontinued use and started corticosteroids.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Different types of scarring alopecia may be stages of one disease, and accurate diagnosis is crucial to prevent permanent hair loss.

Hair transplant surgery effectively treated a specific type of hair loss and is recommended as a primary treatment option.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.